Together, these findings suggest that common polymorphisms in the ASVD risk interval could modulate ANRIL transcription and/or splicing, thereby influencing PcG-mediated INK4/ARF repression and atherosclerosis susceptibility. This evidence concerns the gene CDKN2B-AS1 and atherosclerosis.